Maraganore John

Alnylam Pharmaceuticals Inc.

Chief Executive Officer, Director

Avg. Two Year Performance

(21%) Avg. Purchase Return (10%) Compound

(16%) Avg. Sale Return (8%) Compound

Holdings: 230.8K shares

Last Three Months: 05-Feb-24 -- 04-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

05-May-22 -- 04-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions